We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries. For more information, visit ipsen.com. Pauta exclusiva para México: Clave de Autorización COFEPRIS: 243300201B1962 CONSULTE A SU MÉDICO. Pharmaceuticals, Specialty care: oncology, neuroscience, endocrinology, Research: peptides, toxins, …

Sectors: Pharmaceutical

Building a collaborative ecosystem that leverages the power of deep technologies to tackle world challenges. Hello Tomorrow was created in 2011 by a group of individuals convinced that science and technology need to form part of a toolkit of solutions to change our industries, sustain a growing population and help solve global crises. But the traditional model of technology transfer to bring solutions from lab to market, and from idea to impact, could not rise to this challenge. In turn, Hello Tomorrow has built, and now animates, a global ecosystem that facilitates ‘deep tech’ innovation through multiple activities. Over the …

Sectors: Trade show

[Automatic translation follows] Account of Bpifrance, the Public Investment Bank. Bpifrance, a public investment bank, supports companies from seed to stock market listing, from credit to equity. A privileged contact, Bpifrance offers financing or investment solutions in each region that are adapted to each stage of a company's life. A partner bank for entrepreneurs, Bpifrance provides them with long-term support to support their growth and competitiveness. The teams are at the heart of the regions, throughout the country, through more than 50 regional locations. Financing of SMEs, Business Creation, International Development, Investment, Creation/Transmission, Innovation, Support, Acceleration, and Export Guarantee

Sectors: Bank

[Automatic translation follows] Incubates Deep Tech startups & accelerates scientific innovations from the R&D labs of Lyon-St Etienne 🚀 PULSALYS, the Deep Tech innovation incubator and accelerator of Lyon & St Etienne, builds the innovative products & services of tomorrow, by transforming scientific discoveries from the laboratories of the University of Lyon into economic opportunities for companies and startups. Created in December 2013 as part of the Future Investment Program (PIA) under the status of Technology Transfer Acceleration Company (SATT), PULSALYS has become a key player in the attractiveness and economic development of the Lyon - St-Etienne region. Chemistry & …

Tags: SATT Network Sectors: Research

[Automatic translation follows] #auvergnerhonealpes Auvergne-Rhône-Alpes is a large region with many assets: - With more than 8 million inhabitants, it is more populated than 13 of the 28 countries of the European Union and ranks 10th most populated region in Europe - Covering nearly 70,000 km2, or 13% of the metropolitan territory, its surface area is equivalent to that of Ireland. - In France, it is the leading industrial and gastronomic region, it ranks first for agricultural production under label (AOP, IGP, etc.) and the number of organic farms. - In Europe: it is the 8th richest region in Europe …

Sectors: National and local authorities